Hypoxia, receptor for advanced glycation end products, and cystic fibrosis: A pathway to chronic inflammation?

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 11, 2013, Pages 1280-1281

  McGuire, John K ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN S100B; SOLUBLE ADVANCED GLYCATION END PRODUCT RECEPTOR; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ASTHMA; CELL HYPOXIA; CHLORIDE CHANNELOPATHY; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DRUG TARGETING; EDITORIAL; EMPHYSEMA; GENE EXPRESSION; GENE MUTATION; HUMAN; HYPOXEMIA; HYPOXIA; LUNG CLEARANCE; LUNG INJURY; MODIFIER GENE; MUCOCILIARY CLEARANCE; NONHUMAN; OXYGEN SATURATION; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROTECTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANOXIA; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; PNEUMONIA; RECEPTORS, IMMUNOLOGIC;

EID: 84890066658     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201310-1908ed     Document Type: Editorial

References (16)

1. Goss CH, Ratjen F. Update in cystic fibrosis 2012. Am J Respir Crit Care Med 2013;187:915-919.
2. Hoffman LR, Ramsey BW. Cystic fibrosis therapeutics: the road ahead. Chest 2013;143:207-213.
3. Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci 2010;1214:57-69.
4. Guo WA, Knight PR, Raghavendran K. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome. Intensive Care Med 2012;38:1588-1598.
5. Sukkar MB, Ullah MA, Gan WJ, Wark PA, Chung KF, Hughes JM, Armour CL, Phipps S. RAGE: a new frontier in chronic airways disease. Br J Pharmacol 2012;167:1161-1176.
6. Iannitti RG, Casagrande A, De Luca A, Cunha C, Sorci G, Riuzzi F, BorghiM, Galosi C, Massi-Benedetti C, Oury TD, et al. Hypoxia promotes danger-mediated inflammation via rage in cystic fibrosis. Am J Respir Crit Care Med 2013;188:1338-1350.
7. Shimoda LA, Semenza GL. HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med 2011;183:152-156.
8. Koh MY, Powis G. Passing the baton: the HIF switch. Trends Biochem Sci 2012;37:364-372.
9. Zhou L, Dey CR, Wert SE, DuVall MD, Frizzell RA, Whitsett JA. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science 1994;266:1705-1708.
10. Santilli F, Vazzana N, Bucciarelli LG, Davì G. Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem 2009;16:940-952.
11. Jabaudon M, Futier E, Roszyk L, Chalus E, Guerin R, Petit A, Mrozek S, Perbet S, Cayot-Constantin S, Chartier C, et al. Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 2011;39:480-488.
12. Cheng DT, Kim DK, Cockayne DA, Belousov A, Bitter H, Cho MH, Duvoix A, Edwards LD, Lomas DA, Miller BE, et al.; TESRA and ECLIPSE Investigators. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with ager genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188:948-957.
13. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, et al.; Wellcome Trust Case Control Consortium; NSHD Respiratory Study Team. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010;42:36-44.
14. Beucher J, Boëlle PY, Busson PF, Muselet-Charlier C, Clement A, Corvol H; French C F Modifier Gene Study Investigators. AGER-429T/C is associated with an increased lung disease severity in cystic fibrosis. PLoS ONE 2012;7:e41913.
15. Zheng W, Kuhlicke J, Jäckel K, Eltzschig HK, Singh A, Sjöblom M, Riederer B, Weinhold C, Seidler U, Colgan SP, et al. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J 2009; 23:204-213.
16. Legendre C, Mooij MJ, Adams C, O'Gara F. Impaired expression of hypoxia-inducible factor-1a in cystic fibrosis airway epithelial cells-a role for HIF-1 in the pathophysiology of CF? J Cyst Fibros 2011;10:286-290.